Literature DB >> 7870905

Effects of serotonergic agents on apomorphine-induced locomotor activity.

K A Young1, R Zavodny, P B Hicks.   

Abstract

The interactions of serotonin 5-HT1A, 5-HT1C/2 and 5-HT3 receptor subtypes with apomorphine-induced locomotor activity (AILA) were investigated in Sprague-Dawley rats. The 5-HT3 antagonists ondansetron and ICS 205-930 had no significant effects on AILA. The 5-HT1A agonist 8-hydroxy-2-(di-N-propylamino) tetralin (8-OH-DPAT) produced an increase in locomotor activity that was independent of DA neurotransmission. The locomotor activity induced by co-administration of apomorphine (APO; 0.25 mg/kg) and 8-OH-DPAT (0.25-1.0 mg/kg) was not significantly higher than those induced by APO alone during the peak period of APO stimulation of locomotor activity, nor were they higher than activity induced by 8-OH-DPAT alone during the same time intervals. The 5-HT1 antagonist (1)-propranolol had a depressant effect on AILA, but only at high doses. Coadministration of (1)-propranolol (5 mg/kg) and 8-OH-DPAT (1.0 mg/kg) elevated spontaneous locomotor activity for the first 10 min of the session when compared to 8-OH-DPAT (1.0 mg/kg) alone. The 5-HT2 antagonist ketanserin along with moderate and high doses of mesulergine depressed AILA, effects which may be mediated by the 5-HT2 antagonist properties of these drugs, by nonspecific sedation or by direct effects of these compounds on DA D2 receptors. In contrast to the high-dose mesulergine depression of AILA, a low dose (0.1 mg/kg) of mesulergine elevated AILA, an effect which was blocked by the 5-HT1C/2 agonist 1-(2,-5-dimethoxy-4-iodophenyl) -2-aminopropane (DOI; 1 mg/kg). Neither of these compounds at the doses tested had significant effects on spontaneous locomotor activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870905     DOI: 10.1007/bf02246956

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

Review 1.  The 5-HT1C receptor.

Authors:  P R Hartig; B J Hoffman; M J Kaufman; F Hirata
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release.

Authors:  X M Guan; W J McBride
Journal:  Brain Res Bull       Date:  1989-12       Impact factor: 4.077

3.  Beta-adrenoceptor blockade in rats enhances the ambulation induced by 5-HT1A receptor agonists.

Authors:  H O Kalkman
Journal:  Eur J Pharmacol       Date:  1989-12-07       Impact factor: 4.432

4.  Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain.

Authors:  B J Hoffman; E Mezey
Journal:  FEBS Lett       Date:  1989-04-24       Impact factor: 4.124

5.  The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.

Authors:  L H Jiang; C R Ashby; R J Kasser; R Y Wang
Journal:  Brain Res       Date:  1990-04-09       Impact factor: 3.252

6.  Behavioural effects of serotonin agonists and antagonists in the rat and marmoset.

Authors:  P J Elliott; D M Walsh; S P Close; G A Higgins; A G Hayes
Journal:  Neuropharmacology       Date:  1990-10       Impact factor: 5.250

Review 7.  The concept of selectivity in 5-HT receptor research.

Authors:  I van Wijngaarden; M T Tulp; W Soudijn
Journal:  Eur J Pharmacol       Date:  1990-06-12       Impact factor: 4.432

8.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

9.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

Authors:  R A Glennon; M Titeler; J D McKenney
Journal:  Life Sci       Date:  1984-12-17       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.